propylthiouracil has been researched along with Blood-Loss--Surgical* in 2 studies
1 trial(s) available for propylthiouracil and Blood-Loss--Surgical
Article | Year |
---|---|
The effect of anti-thyroid drug treatment duration on thyroid gland microvessel density and intraoperative blood loss in patients with Graves' disease.
Preoperative preparation of the patient with Graves' disease (GD) is crucial to avoid intraoperative or postoperative complications associated with anesthesia or surgery. We aimed to evaluate thyroid blood flow and microvessel density in patients with GD according to antithyroid drug (ATD) treatment, preoperatively.. Forty-three patients were divided into two groups according to the ATD type. Patients in group 1 (n = 25) were treated with methimazole, whereas patients in group 2 (n = 18) were treated with propylthiouracil, preoperatively. Blood flow through the thyroid arteries was measured by color flow Doppler ultrasonography. The microvessel density (MVD) was assessed immunohistochemically and via Western blot analysis using the level of CD-34expression in thyroid tissue.. There was a positive correlation between blood loss and thyroid volume (r(s) = 0.953, P = .0001) and blood flow (r(s) = 0.720, P = .0001) and CD-34 expression (r(s) = 0.331, P = .03) and MVD (r(s) = 0.442, P = .003). No correlation was observed between ATD type and thyroid vascularity. In patients with longer treatment duration before operation, thyroid vascularity was significantly lower relative to patients with shorter treatment durations. According to logistic regression analysis, longer treatment duration had a 142-fold decreased rate of intraoperative blood loss independent of ATD type.. Preoperative ATD treatment duration may predict intraoperative blood loss during thyroidectomy. Longer treatment duration might be useful in reducing intraoperative bleeding, allowing better visualization and preservation of the nerves and parathyroid glands. Topics: Adolescent; Adult; Antithyroid Agents; Blood Flow Velocity; Blood Loss, Surgical; Female; Graves Disease; Humans; Male; Methimazole; Microcirculation; Middle Aged; Preoperative Care; Propylthiouracil; Reference Values; Thyroid Gland; Thyroidectomy; Ultrasonography, Doppler, Color | 2008 |
1 other study(ies) available for propylthiouracil and Blood-Loss--Surgical
Article | Year |
---|---|
Sodium ipodate (oragrafin) in the preoperative preparation of Graves' hyperthyroidism.
Fourteen Graves' hyperthyroid patients who had been prepared for surgery with sodium ipodate (SI) 500 mg orally twice daily for 3 days were retrospectively studied. SI was administered in combination with propylthiouracil (10 cases) and beta blockers (all cases), which had been previously initiated. Free serum thyroxine (T4) and total triiodothyronine (T3) concentrations were measured before and after SI therapy on the morning of surgery. SI treatment significantly reduced total T3 concentration from 445.9 to 193.4 ng/dL (P < 0.0001) and free T4 concentration from 3.874 to 2.800 ng/dL (P = 0.0003). Preoperatively, only one patient had persistent tachycardia, and intraoperatively this same patient required beta blockers. Blood loss was unremarkable or reduced (average blood loss, 121 mL). On clinical examination glands were firm with normal or somewhat decreased vascularity. On histologic study all glands demonstrated changes consistent with treated Graves' disease. Preoperative treatment with SI appears to be a safe and efficacious method of preparing hyperthyroid patients for surgery. Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Blood Loss, Surgical; Female; Graves Disease; Humans; Ipodate; Male; Premedication; Preoperative Care; Propylthiouracil; Retrospective Studies; Thyroid Gland; Thyroidectomy; Thyrotropin; Thyroxine; Triiodothyronine | 1997 |